NUVAXOVID

Swiss trademark · 825973 · Word mark · In force

Register entry

Registration number
825973
Application number
00995/2025
Status
In force
Type
Word mark
Filed
Jan 25, 2021
Registered
Jan 30, 2025
Published
Jan 30, 2025
Protected until
Jan 25, 2031
Priority
25.07.2020 US
25.07.2020 US
Remarks
Umwandlung der internationalen Registrierung Nr. 1580281 (Art. 46a MschG).
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Vaccines

As filed

Vaccins.

Science, technology and IT

Fourniture d'informations en matière de recherche médicale et scientifique dans le domaine des vaccins, de la biomédecine, des essais cliniques et des essais post-commercialisation; services de conseillers dans le domaine de la recherche et du développement de vaccins; recherche et développement de vaccins.

Translated automatically. Only the text as filed is legally binding.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 30, 2025

    Registered

    Published in Swissreg on 30.01.2025

Parties

Holder

Novavax, Inc.

20 Firstfield Road, Gaithersburg, MD 20878, US

Agent

Troller Hitz Troller, Rechtsanwälte

Schweizerhofquai 2 Postfach 6002 Luzern

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.